1. Coagulation abnormalities in childhood acute lymphoblastic leukemia: assessing the impact of L-asparaginase therapy in Ghana
- Author
-
Ganiwu Abdul, David Ofosu Ntiamoah, Otchere Addai-Mensah, Eddie-Williams Owiredu, Gordon Asare Akuffo, Benedict Sackey, Michael Owusu, Alexander Yaw Debrah, William Osei-OWusu, Selina Mintaah, Lilian Antwi-Boateng, and Max Efui Annani-Akollor
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Context (language use) ,Thromboembolic complications ,030204 cardiovascular system & hematology ,Acute lymphoblastic leukemia ,Gastroenterology ,Protein S ,03 medical and health sciences ,Hypercoagulability ,0302 clinical medicine ,Internal medicine ,medicine ,Diseases of the blood and blood-forming organs ,Childhood Acute Lymphoblastic Leukemia ,Prothrombin time ,Chemotherapy ,Hematology ,medicine.diagnostic_test ,biology ,business.industry ,Research ,Antithrombin ,Thrombosis ,biology.protein ,030211 gastroenterology & hepatology ,RC633-647.5 ,business ,medicine.drug ,Partial thromboplastin time - Abstract
Background Although the rate of childhood acute lymphoblastic leukemia (ALL) is increasing in Africa, there is a dearth of information on the disease and the dynamics of hemostatic parameters with therapy. Methods In this case-control study, we evaluated variations in the level/activity of selected coagulation parameters among cALL in Ghana and healthy controls stratified by stage of therapeutic management. Results In all, the research recruited 104 participants comprising 26 cALL cases and 78 healthy controls. The cALL group had significantly higher prothrombin time (PT) (p = 0.001), activated partial thromboplastin time (APTT) (p p = 0.001) but lower platelet (PLT) count, protein C (PC) (p p p p p = 0.005) and maintenance phases of chemotherapy (p = 0.012) while activities of PS and ATIII were lower at both induction (p p = 0.006) and consolidation (p p = 0.018) phases of chemotherapy. Conclusion Our findings provide evidence in the context of Africa and corroborates previous reports that cALL could result in a state of hypercoagulability, possibly leading to a high risk of thrombosis and thromboembolic complications. This possibly increased risk is not limited to the induction phase but also the consolidation phase.
- Published
- 2021